Time to consider sequencing anti-inflammatory treatments with chemotherapy and immuno-stimulation?

Time to consider sequencing anti-inflammatory treatments with chemotherapy and immuno-stimulation?

Bibliographic Details
Main Author:	George Blanck
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-12-01
Series:	Frontiers in Immunology
Subjects:	immunoediting CDR3-antigen chemical complementarity scoring granzyme B immune checkpoint blockade cancer and inflammation
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.1082142/full

Similar Items

Modulation of Inflammation by Extracellular Granzyme A
by: Kim R. van Daalen, et al.
Published: (2020-05-01)

Balance and modulation of immunoediting for cancer treatment using synergistic nano-photo-immuno effects
by: Hoover Ashley R., et al.
Published: (2021-08-01)

Tyrosine Sulfation at Antibody Light Chain CDR-1 Increases Binding Affinity and Neutralization Potency to Interleukine-4
by: Aaron M. D’Antona, et al.
Published: (2024-02-01)

Electrostatic Complementarities of Glioblastoma-Resident T-Cell Receptors and Cancer Testis Antigens Linked to Poor Outcomes and High Levels of Sphingosine Kinase-2 Expression
by: Miguel A. Arias, et al.
Published: (2023-04-01)

Immunoediting-induced Immunotherapy Resistance
by: LYU LYU, et al.
Published: (2020-04-01)

Humanization of Antibodies using a Statistical Inference Approach
by: Alejandro Clavero-Álvarez, et al.
Published: (2018-10-01)

Pre-treatment tumor neo-antigen responses in draining lymph nodes are infrequent but predict checkpoint blockade therapy outcome
by: Shaokang Ma, et al.
Published: (2020-01-01)

Exposure of Immunogenic Tumor Antigens in Surrendered Immunity and the Significance of Autologous Tumor Cell-Based Vaccination in Precision Medicine
by: Chiao-Hsu Ke, et al.
Published: (2022-12-01)

Antibody-Antigen Binding Interface Analysis in the Big Data Era
by: Pedro B. P. S. Reis, et al.
Published: (2022-07-01)

Immuno-Oncology: Emerging Targets and Combination Therapies
by: Henry T. Marshall, et al.
Published: (2018-08-01)

Granzyme B PET Imaging of the Innate Immune Response
by: Kathleen M. Capaccione, et al.
Published: (2020-07-01)

A potential antibody repertoire diversification mechanism through tyrosine sulfation for biotherapeutics engineering and production
by: Xiaotian Zhong, et al.
Published: (2022-12-01)

The Immuno-Modulatory Effects of Inhibitor of Apoptosis Protein Antagonists in Cancer Immunotherapy
by: Jessica Michie, et al.
Published: (2020-01-01)

A Proposed Link Between Acute Thymic Involution and Late Adverse Effects of Chemotherapy
by: Maria K. Lagou, et al.
Published: (2022-07-01)

Cutaneous Squamous Cell Carcinoma in the Age of Immunotherapy
by: Yosuke Ishitsuka, et al.
Published: (2021-03-01)

Development of a human immuno-oncology therapeutic agent targeting HER2: targeted delivery of granzyme B
by: Lawrence H. Cheung, et al.
Published: (2019-07-01)

NK- and T-cell granzyme B and K expression correlates with age, CMV infection and influenza vaccine-induced antibody titres in older adults
by: Chris P. Verschoor, et al.
Published: (2023-01-01)

Single-cell Analysis Technologies for Immuno-oncology Research: from Mechanistic Delineation to Biomarker Discovery
by: Zhiliang Bai, et al.
Published: (2021-04-01)

Tumor-Infiltrating Dendritic Cells: Decisive Roles in Cancer Immunosurveillance, Immunoediting, and Tumor T Cell Tolerance
by: Theodora Katopodi, et al.
Published: (2022-10-01)

Role of the granzyme family in rheumatoid arthritis: Current Insights and future perspectives
by: Yixin Zheng, et al.
Published: (2023-02-01)

Fundamental Principles of Raising an Antitumour Immune Response in Vivo: A Complex Model, a Case Report, and a Perspective
by: Suzy M. Scholl
Published: (2014-11-01)

Do antibody CDR loops change conformation upon binding?
by: Chu’nan Liu, et al.
Published: (2024-12-01)

Type I and II Interferons in the Anti-Tumor Immune Response
by: Sarah E. Fenton, et al.
Published: (2021-03-01)

Response to Immune Checkpoint Inhibitors Is Affected by Deregulations in the Antigen Presentation Machinery: A Systematic Review and Meta-Analysis
by: Maria Rasmussen, et al.
Published: (2022-12-01)

Modeling Immune Checkpoint Inhibitor Efficacy in Syngeneic Mouse Tumors in an Ex Vivo Immuno-Oncology Dynamic Environment
by: Daniel T. Doty, et al.
Published: (2020-09-01)

Dynamics of Melanoma-Associated Epitope-Specific CD8+ T Cells in the Blood Correlate With Clinical Outcome Under PD-1 Blockade
by: Andrea Gaißler, et al.
Published: (2022-07-01)

The senescence journey in cancer immunoediting
by: Alessandra Zingoni, et al.
Published: (2024-04-01)

Inflammation, Infiltration, and Evasion—Tumor Promotion in the Aging Breast
by: Nicole Cruz-Reyes, et al.
Published: (2023-03-01)

Exosomes in cancer immunoediting and immunotherapy
by: Yarong Zhao, et al.
Published: (2022-03-01)

Have Cells Harboring the HIV Reservoir Been Immunoedited?
by: Szu-Han Huang, et al.
Published: (2019-08-01)

Granzymes in health and diseases: the good, the bad and the ugly
by: Lavinia Cigalotto, et al.
Published: (2024-04-01)

Intracellular and Extracellular Roles of Granzyme K
by: Annemieke C. Bouwman, et al.
Published: (2021-05-01)

Decreased Expression of Cytotoxic Proteins in Decidual CD8<sup>+</sup> T Cells in Preeclampsia
by: Violeta Soljic, et al.
Published: (2021-10-01)

Editorial: Factors determining long term anti-tumor responses to immune checkpoint blockade therapy
by: Roberta Zappasodi, et al.
Published: (2022-12-01)

Durable Responses to Anti-PD1 and Anti-CTLA4 in a Preclinical Model of Melanoma Displaying Key Immunotherapy Response Biomarkers
by: Elena Shklovskaya, et al.
Published: (2022-10-01)

Stromal score is a promising index in tumor patients’ outcome determination
by: Xiaoxian Xu, et al.
Published: (2023-11-01)

Immuno-Oncology Biomarkers for Personalized Immunotherapy in Breast Cancer
by: Vida Vafaizadeh, et al.
Published: (2020-03-01)

Balancing sensitivity and specificity in distinguishing TCR groups by CDR sequence similarity
by: Neerja Thakkar, et al.
Published: (2019-05-01)

Restriction site associated DNA sequencing for tumour mutation burden estimation and mutation signature analysis
by: Conor F. McGuinness, et al.
Published: (2023-12-01)

Quantitative Description of Surface Complementarity of Antibody-Antigen Interfaces
by: Lorenzo Di Rienzo, et al.
Published: (2021-09-01)